by Keyvan Koushan, MD, FRCSC
A journal club to review recent journal articles in the field of retina. The target audience are retina specialists and other healthcare professionals who want to stay up-to-date with the latest publications in the field of retina.
Language
🇺🇲
Publishing Since
10/23/2017
Email Addresses
1 available
Phone Numbers
0 available
April 15, 2025
<p>Dr. Wu discusses prospective cognitive outcomes of children who had treatment for Retinopathy of Prematurity. The analysis suggests that cognitive outcomes were similar for children who had either laser or anti-VEGF injections for ROP treatment.<span class= "Apple-converted-space"> </span></p> <p>Dr. Wu will be one of the invited guest speakers at the Canadian Retina Society meeting in Vancouver, BC from April 25-April 27, 2025. You can register for this meeting at:</p> <p><strong><a href= "https://crsscr.ca/meeting">https://crsscr.ca/meeting</a></strong></p> <p> </p> <p>Discussed article:</p> <p>Wu PL, Shih CP, Huang YS, Chen HC, Hsueh YJ, Lee CW, Chiang MC, Lien R, Lee CC, Chu SM, Chou HD, Liu L, Chen KJ, Hwang YS, Lai CC, Wu WC. ADMINISTERING INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY: 8-Year Cognitive Outcomes In A Prospective Cohort. Retina. 2024 Nov 1;44(11):1952-1960. doi: 10.1097/IAE.0000000000004222. PMID: 39121508.</p>
March 9, 2025
<p>This episode is a recording of the retina-focused EyeNovation webinar episode which was a collaboration between Canadian Ophthalmological Society and the Canadian Retina Society. Dr. Chakravarthy will provide a background to the double layer sign, its definition and how it is detected. Data to support the presentation will be from the EDNA trial . This study possesses an imaging dataset that was captured longitudinally in over 500 high risk eyes and obtained robust rates of progression to neovascularization as well as time to the event. The presence of the DLS and or other features of intermediate AMD were assessed at baseline and included measurements of length of separation of the RPE from its basement membrane, height of separation and the number of B scans involved. Rates of progression in eyes without and with DLS were computed and models built to assess risk of progression to neovascularization. In addition the DLS and SIRE signs were compared for their contributions to risk of progression. The findings from these analyses and their clinical significance will be discussed .</p> <p><strong>Make sure to register for the Canadian Retina Society (CRS) annual meeting which will take place in Vancouver, BC from April 25-27, 2025. Go to https://www.crsscr.ca to register.</strong></p>
January 12, 2025
Dr. Rohan Muni discusses long-term reattachment rates of PIVOT and Suprachoroidal Viscopexy for RD repair, offering insights into novel in-office methods and best practices for retinal detachment repair.
Jonathan L. Prenner, MD
Retina Today
Whipsmart Media
American Society of Retina Specialists (ASRS)
Drs. Akshay Thomas & Laura Kopplin.
American Academy of Ophthalmology
American Academy of Ophthalmology
JAMA Network
MayoClinicOphthalmology
Eyetube
Eyetube
Ben Young and Andrew Pouw
Human Content
Roman Mars
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.